| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| APLS | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | Mar 01, 2024 | Option Exercise | $4.20 | 250,000 | 1,050,000 | 563,662 | Mar 05, 2024, 04:07 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | Mar 01, 2024 | Sale | $64.11 | 250,000 | 16,028,706 | 534,794 | Mar 05, 2024, 04:07 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | Feb 12, 2024 | Sale | $67.77 | 3,962 | 268,492 | 313,662 | Feb 13, 2024, 04:49 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | Jan 29, 2024 | Sale | $64.14 | 2,843 | 182,345 | 317,624 | Jan 31, 2024, 04:26 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | Jan 22, 2024 | Sale | $65.00 | 13,431 | 872,961 | 320,467 | Jan 23, 2024, 07:28 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | Jan 16, 2024 | Sale | $66.81 | 7,851 | 524,514 | 333,898 | Jan 17, 2024, 04:32 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | Nov 21, 2023 | Sale | $48.80 | 5,000 | 244,000 | 269,655 | Nov 21, 2023, 05:36 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | Sep 01, 2023 | Option Exercise | $2.67 | 300,000 | 801,000 | 574,655 | Sep 01, 2023, 04:05 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | Sep 01, 2023 | Sale | $41.75 | 150,000 | 6,262,959 | 434,939 | Sep 01, 2023, 04:05 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | May 16, 2023 | Option Exercise | $2.67 | 30,000 | 80,100 | 304,655 | May 18, 2023, 05:10 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | May 16, 2023 | Sale | $85.66 | 30,000 | 2,569,900 | 303,721 | May 18, 2023, 05:10 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | May 17, 2023 | Option Exercise | $2.67 | 20,000 | 53,400 | 294,655 | May 18, 2023, 05:10 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | Apr 19, 2023 | Option Exercise | $2.67 | 20,000 | 53,400 | 657,601 | Apr 20, 2023, 04:51 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | Apr 18, 2023 | Option Exercise | $2.67 | 30,000 | 80,100 | 667,601 | Apr 20, 2023, 04:51 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | Apr 18, 2023 | Sale | $82.02 | 30,000 | 2,460,720 | 637,601 | Apr 20, 2023, 04:51 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | Mar 21, 2023 | Option Exercise | $2.67 | 30,000 | 80,100 | 1,174,591 | Mar 23, 2023, 04:55 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | Mar 21, 2023 | Sale | $62.74 | 30,000 | 1,882,332 | 1,144,591 | Mar 23, 2023, 04:55 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | Mar 22, 2023 | Option Exercise | $4.16 | 127,221 | 529,411 | 1,271,812 | Mar 23, 2023, 04:55 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | Feb 27, 2023 | Option Exercise | $3.76 | 100,000 | 376,000 | 1,144,591 | Mar 01, 2023, 04:10 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | Feb 21, 2023 | Option Exercise | $58.50 | 1,602 | 93,717 | 1,044,591 | Feb 22, 2023, 06:40 AM | |
| APLS | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | Feb 10, 2023 | Option Exercise | $51.21 | 3,958 | 202,689 | 1,032,285 | Feb 14, 2023, 04:42 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | Jan 27, 2023 | Option Exercise | $52.77 | 2,879 | 151,925 | 1,036,243 | Jan 30, 2023, 04:59 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | Jan 20, 2023 | Option Exercise | $52.05 | 9,453 | 492,029 | 1,039,122 | Jan 24, 2023, 05:17 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | Dec 19, 2022 | Sale | $52.06 | 28,200 | 1,467,983 | 989,577 | Dec 21, 2022, 04:13 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | Dec 19, 2022 | Option Exercise | $4.64 | 49,888 | 231,680 | 993,328 | Dec 21, 2022, 04:13 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | Jan 28, 2022 | Option Exercise | $38.59 | 2,024 | 78,106 | 1,338,463 | Feb 01, 2022, 06:00 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | Jul 21, 2021 | Option Exercise | $4.31 | 14,410 | 62,107 | 1,234,243 | Jul 22, 2021, 04:04 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | Feb 10, 2021 | Option Exercise | $47.72 | 2,523 | 120,398 | 1,219,833 | Feb 11, 2021, 04:05 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | Feb 10, 2021 | Option Exercise | $47.72 | 2,523 | 120,398 | 1,219,833 | Feb 11, 2021, 04:05 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | Jan 27, 2021 | Option Exercise | $4.01 | 71,777 | 287,477 | 1,184,856 | Jan 29, 2021, 04:19 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | Dec 15, 2020 | Sale | $52.16 | 5,000 | 260,800 | 1,113,079 | Dec 16, 2020, 04:35 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | Dec 01, 2020 | Option Exercise | $3.76 | 40,000 | 150,400 | 1,118,079 | Dec 02, 2020, 04:31 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | Nov 16, 2020 | Sale | $39.38 | 5,000 | 196,900 | 1,078,079 | Nov 17, 2020, 07:13 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | Oct 15, 2020 | Sale | $34.46 | 5,000 | 172,300 | 1,083,079 | Oct 16, 2020, 05:31 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | Sep 15, 2020 | Sale | $30.96 | 5,000 | 154,800 | 1,088,079 | Sep 16, 2020, 04:03 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | Aug 20, 2020 | Sale | $30.00 | 3,457 | 103,710 | 1,093,079 | Aug 21, 2020, 04:36 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | Aug 18, 2020 | Sale | $30.00 | 1,543 | 46,290 | 1,096,536 | Aug 20, 2020, 04:45 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | Jul 15, 2020 | Sale | $32.12 | 5,000 | 160,600 | 1,098,079 | Jul 16, 2020, 04:07 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | Jun 15, 2020 | Sale | $30.21 | 5,000 | 151,050 | 1,103,079 | Jun 16, 2020, 04:39 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | May 15, 2020 | Sale | $29.92 | 5,000 | 149,600 | 1,108,079 | May 19, 2020, 04:27 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | Apr 15, 2020 | Sale | $29.77 | 5,000 | 148,850 | 1,113,079 | Apr 17, 2020, 07:32 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | Mar 16, 2020 | Option Exercise | $2.14 | 30,637 | 65,563 | 1,088,704 | Mar 18, 2020, 04:51 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | Mar 16, 2020 | Sale | $21.32 | 35,637 | 759,934 | 1,086,596 | Mar 18, 2020, 04:51 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | Mar 17, 2020 | Option Exercise | $2.14 | 30,637 | 65,563 | 1,083,704 | Mar 18, 2020, 04:51 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | Feb 19, 2020 | Option Exercise | $2.14 | 30,637 | 65,563 | 1,058,067 | Feb 20, 2020, 04:07 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | Feb 18, 2020 | Option Exercise | $2.14 | 30,637 | 65,563 | 1,063,067 | Feb 20, 2020, 04:07 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | Feb 18, 2020 | Sale | $40.66 | 35,637 | 1,449,122 | 1,032,430 | Feb 20, 2020, 04:07 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | Jan 16, 2020 | Option Exercise | $2.14 | 30,637 | 65,563 | 1,032,430 | Jan 21, 2020, 09:22 AM | |
| APLS | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | Jan 15, 2020 | Option Exercise | $2.14 | 30,638 | 65,565 | 1,001,793 | Jan 17, 2020, 04:11 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | Jan 15, 2020 | Sale | $42.11 | 35,638 | 1,500,788 | 1,011,355 | Jan 17, 2020, 04:11 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | Dec 16, 2019 | Sale | $27.95 | 5,000 | 139,750 | 1,006,793 | Dec 17, 2019, 04:47 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | Nov 15, 2019 | Sale | $27.28 | 5,000 | 136,405 | 1,011,793 | Nov 18, 2019, 04:21 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | Oct 15, 2019 | Sale | $26.31 | 5,000 | 131,551 | 1,020,317 | Oct 16, 2019, 04:02 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | Sep 16, 2019 | Sale | $26.59 | 5,000 | 132,949 | 1,022,053 | Sep 17, 2019, 07:29 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | Aug 23, 2019 | Option Exercise | $2.67 | 37,505 | 100,138 | 1,026,793 | Aug 26, 2019, 04:10 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | Aug 15, 2019 | Sale | $26.80 | 10,000 | 268,007 | 991,534 | Aug 16, 2019, 04:08 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | Aug 15, 2019 | Option Exercise | $2.14 | 10,000 | 21,400 | 999,288 | Aug 16, 2019, 04:08 PM | |
| APLS | Apellis Pharmaceuticals, Inc. | Francois Cedric | Chief Executive Officer | Jun 27, 2019 | Option Exercise | $2.14 | 275,000 | 588,500 | 989,288 | Jul 01, 2019, 04:09 PM |
Menu